Position in MRK
as of Jun 30, 2026
· filed Jul 10, 2026
Position Value
$1,066,678
+$172,683 QoQ
Shares Held
8,301
+11.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.28%
of 13F equity value
Holder Rank
#2,069
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026West Branch Capital LLC holds $28,624,658 across 10 Drug Manufacturers - General names. MRK ranks #4 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
8,703 | $10,438,640 | |
| 2 | JNJ |
Johnson & Johnson
|
33,416 | $8,486,661 | |
| 3 | ABBV |
AbbVie Inc.
|
30,433 | $7,658,160 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
8,301 | $1,066,678 | |
| 5 | AMGN |
Amgen Inc
|
1,167 | $422,594 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,186 | $276,179 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
2,350 | $135,407 | |
| 8 | PFE |
Pfizer Inc
|
4,359 | $104,964 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,066,678 | 8,301 | Shares | Sole | 2026-07-10 | |
| 2026-03-31 | $893,995 | 7,432 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $549,772 | 5,223 | Shares | Sole | 2026-01-16 | |
| 2025-09-30 | $1,770,755 | 21,098 | Shares | Sole | 2025-10-21 | |
| 2025-06-30 | $1,923,271 | 24,296 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,245,436 | 25,016 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $2,155,433 | 21,667 | Shares | Sole | 2025-01-17 | |
| 2024-09-30 | $2,239,062 | 19,717 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $2,315,555 | 18,704 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $2,411,782 | 18,278 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $1,876,561 | 17,213 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,682,203 | 16,340 | Shares | Sole | 2023-10-20 | |
| 2023-06-30 | $1,884,203 | 16,329 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $1,738,731 | 16,343 | Shares | Sole | 2023-04-20 | |
| 2022-12-31 | $1,780,525 | 16,048 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $1,381,192 | 16,038 | Shares | Sole | 2022-10-19 | |
| 2022-06-30 | $1,423,163 | 15,610 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $1,283,262 | 15,640 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $1,232,524 | 16,082 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $1,172,542 | 15,611 | Shares | Sole | 2021-11-09 | |
| 2021-06-30 | $1,269,439 | 16,323 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $1,205,379 | 15,636 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $1,416,284 | 17,314 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $1,385,846 | 16,707 | Shares | Sole | 2020-10-13 | |
| 2020-06-30 | $1,239,523 | 16,029 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $926,588 | 12,043 | Shares | Sole | 2020-04-20 | |
| No filing history on record for this holder in this stock. | ||||||